+++++++++++++++++++++++++++++++++++++++++++++++++
Posted Mon, 16 Jan 2012 15:37:59
This message was forwarded through MEDSOCNEWS.
If you wish to make an announcement or publicise
an event then please send the text to:
[log in to unmask]
You can follow us on twitter @MedSocNews
+++++++++++++++++++++++++++++++++++++++++++++++++

Colleagues may be interested in the following event:

Posted on behalf of Jennie Bristow, Department of press and public policy, BPAS, Editor, Abortion Review, www.abortionreview.org, Tel: 07976 414751

PILLS IN PRACTICE: IS ABORTION AND CONTRACEPTION POLICY MEETING WOMEN’S NEEDS?
Women in Britain generally receive free and timely access to abortion, contraception and emergency contraception. These are important and welcome developments. But do they go far enough? This one-day public conference, organised by British Pregnancy Advisory Service (BPAS) in London on Friday 11 May 2012, brings together clinicians, academics, advocates and service providers from the UK, Europe and the USA to discuss the future of abortion and contraception in Britain.  

Home abortions: Do we medicalise too much?
The development of abortion pill means that a greater proportion of abortions takes place in early pregnancy; yet the legal framework surrounding the use of early medical abortion drugs in Britain is at odds with research, clinical guidance, and established best practice in other developed countries. This keynote session examines pioneering international research into the abortion pill, and discusses the political, cultural and legal barriers that can prevent its translation into practice.
- Beverly Winikoff, President, Gynuity Health Projects, USA
- Sam Rowlands LLM MD FRCGP FFSRH, Dorset HealthCare University NHS Foundation Trust and University of Warwick
- Raha Shojai MD MSc, North University Hospital of Marseilles, France
- Kinga Jelinska, project manager, Women on Web, the Netherlands
- Kate Greasley, Dphil candidate in law, New College, Oxford; Lecturer in Law, Hertford College, Oxford

Contraception: LARCs and their limits
This session examines developments in Long-Acting Reversible Contraceptives (LARCs) such as the implant and the coil. Why aren’t more women using them, and are women’s expectations of ‘fit and forget’ methods appropriately managed? Would greater uptake of these methods have an impact on the number of ‘repeat’ abortions, or would policymakers do better to move away from such instrumental targets? 
- James Trussell, Professor of Economics and Public Affairs at Princeton University; visiting professor, the Hull York Medical School
- Dawn Clark, Psychologist, the London Research Centre for Therapeutic Education
- Kaye Wellings, Professor of Sexual and Reproductive Health Research at London School of Hygiene and Tropical Medicine
- Joanne Fletcher, Consultant Nurse Gynaecology, Sheffield

Contraception: Will the Pill survive a century?
Over 50 years on from the Pill’s introduction into Britain, why has there been no progress in over-the-counter provision? While there have been improvements in access to the morning-after pill, why aren’t we making more of it? How does the broader cultural climate affect developments in contraceptive methods, and women’s attitudes towards them?
 - Christian Fiala MD, PhD, Medical Director, Gynmed Clinic for Contraception and Abortion, Vienna and Salzburg, Austria
 - Lara Marks, author, Sexual Chemistry: A history of the contraceptive pill 
- Ann Furedi, chief executive of BPAS

 'Late' abortions and fetal anomaly – Towards a woman-centred service
What are the particular issues facing women seeking abortion for fetal anomaly, and how could Britain’s ‘late abortion’ service in general be developed and improved? What are the problems and opportunities involved in recruiting and training a new generation of abortion doctors? 
- Jane Fisher, Director, Antenatal Results and Choices
- Stephen Robson MB BS MRCOG MD, Professor of Fetal Medicine, Newcastle University
- Helen Statham, Deputy Director and Senior Research Associate, Centre for Family Research, University of Cambridge
- Kate Guthrie, Clinical Director, Hull and East Riding Sexual and Reproductive Healthcare Partnership
- Ellie Lee, Reader in Social Policy and Director, Centre for Parenting Culture Studies, University of Kent

The future of Britain’s abortion service
Ann Furedi, chief executive of BPAS, will summarise the prospects and barriers to developing the kind of abortion service that women need and deserve in the twenty-first century. 

FURTHER INFORMATION
DATE: Friday 11 May 2012
VENUE: Royal Society of Medicine, London W1G OAE
TIME: 9am-5pm (Registration from 8.30am)
TICKETS (Early bird rate - until 30 March 2012): 
Clinical/management - £95 
Nursing/midwifery/academic - £75 
Unwaged/student - £35 

To purchase tickets, please follow this link:
http://site.futureofabortion.org/page.php?licenseKey=8b574771a7d3dbae5daf1a0d07ba5bd2&ID=2193 
For more information, please see the conference website: www.futureofabortion.org or email [log in to unmask]

**********************************************************************
1. For general enquires or problems with the list or to CHANGE YOUR EMAIL ADDRESS send a message to:
[log in to unmask]
2. To suspend yourself from the list, whilst on leave, for example,
send an email to [log in to unmask] with the following message:
set medsocnews nomail
3. To resume email from the list, send the following message:
set medsocnews mail
4. To leave MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
leave medsocnews
5. To join or subscribe to MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
SUBSCRIBE medsocnews firstname lastname
6. Further information about the medsocnews discussion list (including
list archive and how to subscribe to or leave the list) can be found
at the list web site:
http://www.jiscmail.ac.uk/lists/medsocnews.html
**********************************************************************